Cartilage Repair Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Cartilage Repair Market size was valued at USD 789.3 million in 2023 and is projected to grow at a CAGR of over 10% between 2024 and 2032. Advancements in regenerative medicine, including stem cell therapy and growth factor treatments, are providing promising non-surgical options for cartilage repair, contributing to market progress.
Increased awareness of the importance of cartilage health and the availability of cartilage repair options has led more people to seek treatment for joint pain and injuries. Further, the introduction of biological products, such as autologous chondrocyte implantation (ACI) and cartilage-derived scaffolds, has enhanced the effectiveness of cartilage repair, boosting demand for these treatments. Moreover, as healthcare expenditure continues to increase in many regions, patients have more access to cartilage repair procedures and technologies.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Cartilage Repair Market Size in 2023: | USD 789.3 Million |
Forecast Period: | 2024 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 10 |
2023 Value Projection: | USD 1.87 Billion |
Historical Data for: | 2018 to 2023 |
No of Pages: | 190 |
Tables, Charts & Figures: | 384 |
Segments Covered: | Modality, Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Cartilage repair refers to the process of restoring damaged or injured cartilage, a tough and flexible connective tissue that covers the ends of bones in joints, such as the knee, hip, and shoulder. Cartilage serves as a cushion and provides a smooth surface for joint movement. When cartilage is damaged due to injury, degeneration, or disease, it can lead to pain, reduced joint function, and the development of conditions like osteoarthritis.
The cartilage repair market experienced a negative impact due to the COVID-19 pandemic. Elective surgeries, including many cartilage repair procedures, were postponed, or cancelled to allocate healthcare resources for COVID-19 patients. This led to a decline in the number of surgeries and a reduction in revenue for healthcare providers and manufacturers of cartilage repair products. Patients were often reluctant to seek medical care for non-urgent orthopedic issues, further impacting the market. However, with the gradual resumption of elective procedures and an increased focus on regenerative medicine, the cartilage repair industry is expected to rebound, but recovery may take time.
Osteoarthritis is a common degenerative joint condition characterized by the breakdown of cartilage in the joints. As the population ages and obesity rates rise, the prevalence of osteoarthritis has been steadily increasing. For instance, according to the Centers for Disease Control and Prevention (CDC), osteoarthritis affects over 32.5 million adults in the U.S.
The market by modality is categorized into cell based, and non-cell based. The cell-based segment accounted for around USD 450 million revenue in 2022. Cell-based treatments can be tailored to the patient's specific needs. This customization can lead to more effective and targeted cartilage repair, potentially improving patient outcomes.
Based on type, the cartilage repair market is bifurcated into hyaline cartilage and fibrocartilage. The hyaline cartilage segment accounted for over 53% market share in 2022 and is projected to record highest growth during the forecast period.
Based on application, the cartilage repair market is segmented into knee, hip, and others. The knee segment held significant share and accounted for over USD 373 million in 2022.
The cartilage repair market by end-use is categorized into hospitals and clinics, and ambulatory surgical centers. The hospitals and clinics segment was valued at USD 547 million revenue in 2022. Primary care physicians often refer patients with joint issues to orthopedic specialists in hospitals and clinics. This referral process has increased the number of patients seeking cartilage repair services in these settings.
North America cartilage repair market accounted for over USD 364 million revenue in 2022 and is predicted to witness substantial market growth over the forecast timeline. Health insurance coverage in North America often includes orthopedic procedures, making cartilage repair accessible to a larger portion of the population.
The cartilage repair industry is competitive in nature, with leading companies competing to offer superior products in this business space. Prominent players such as Zimmer Biomet, Vericel Corporation, CONMED Corporation, Arthrex, Inc., and Stryker Corporation hold a significant share in this market. These companies are diligently directing their efforts towards continuous product innovation to improve their market presence.
Some of the eminent market participants operating in the cartilage repair industry include:
By Modality, 2018-2032 (USD Million)
By Type, 2018-2032 (USD Million)
By Application, 2018-2032 (USD Million)
By End-use, 2018-2032 (USD Million)
The above information is provided for the following regions and countries:
Some of the leading cartilage repair companies are Zimmer Biomet, Smith & Nephew Plc, Arthrex, Inc., Conmed Corporation, B. Braun Melsungen AG, Stryker Corporation, Vericel Corporation, Anika Therapeutics, Inc., Johnson & Johnson Services, Inc., and Becton, Dickinson and Company.
Cartilage repair industry was worth USD 789.3 million in 2023 and is estimated to reach USD 1.87 billion by 2032 attributed to the growing advancements in regenerative medicine worldwide.
The hyaline cartilage segment held more than 55% share of the cartilage repair industry in 2022 and is set to witness high demand through 2032 owing to the increasing number of injuries to articular cartilage among athletes.
North America cartilage repair industry size was more than USD 364 million in 2022 and is set to expand at robust pace through 2032 owing to the availability of health insurance coverage, including orthopedic procedures.